Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05105477 · ClinicalTrials.gov registry record · NA
Hypotension Prediction Index (HPI) SMART-BP Trial
A NA study, sponsored by Edwards Lifesciences.
- Terminated
- Registry status
- NA
- Development phase
- 407
- Enrollment target
NCT05105477: Clinical Trial NA study, sponsored by Edwards Lifesciences.
NCT05105477 is a NA study that was terminated before completion, run by Edwards Lifesciences. The registered enrollment target is 407 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05105477, a NA study, was terminated before completion, sponsored by Edwards Lifesciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 407 participants
- Enrollment target
Study Summary
A multicenter, randomized comparison of intraoperative hemodynamic management with or without a protocolized strategy utilizing Hypotension Prediction Index (HPI) software guidance during moderate-to-high-risk noncardiac surgery.
Primary Outcome
A composite of 30-day moderate-to-severe perfusion related postoperative complications.
Interventions
- DEVICE AcumenTM HPI Software Feature
- OTHER Non-protocolized Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 407 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
Why NCT05105477 stopped before completion
NCT05105477 is an interventional study that assigns participants to a tested intervention. The registered 407 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which AcumenTM HPI Software Feature is the first listed.
NCT05105477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05105477 about?
NCT05105477 is a clinical study titled "Hypotension Prediction Index (HPI) SMART-BP Trial". A multicenter, randomized comparison of intraoperative hemodynamic management with or without a protocolized strategy utilizing Hypotension Prediction Index (HPI) software guidance during moderate-to-high-risk noncardiac surgery.
What is the current status of trial NCT05105477?
This trial is currently terminated. It is a NA study. The enrollment target is 407 participants. The study started on 2021-11-17. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05105477?
The interventions under investigation include: AcumenTM HPI Software Feature (DEVICE), Non-protocolized Standard of Care (OTHER).
Who is sponsoring clinical trial NCT05105477?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05105477's enrollment target sits among peer trials
407 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
- NCT07094516 · 407 participants · Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI